Table of Contents

company-logo

Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Enochian Biosciences, Inc. and changed its name to Renovaro Biosciences Inc. in August 2023. Renovaro Biosciences Inc. is headquartered in Los Angeles, California.

Renovaro Biosciences Dividend Announcement

• Renovaro Biosciences does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Renovaro Biosciences dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Renovaro Biosciences Dividend History

Renovaro Biosciences Dividend Yield

Renovaro Biosciences current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Renovaro Biosciences stock? Use our calculator to estimate your expected dividend yield:

Renovaro Biosciences Financial Ratios

P/E ratio-1.35
PEG ratio-0.01
P/B ratio0.48
ROE-47.54%
Payout ratio0.00%
Current ratio0.07
Quick ratio0.08
Cash Ratio0.01

Renovaro Biosciences Dividend FAQ

Does Renovaro Biosciences stock pay dividends?
Renovaro Biosciences does not currently pay dividends to its shareholders.
Has Renovaro Biosciences ever paid a dividend?
No, Renovaro Biosciences has no a history of paying dividends to its shareholders. Renovaro Biosciences is not known for its dividend payments.
Why doesn't Renovaro Biosciences pay dividends?
There are several potential reasons why Renovaro Biosciences would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Renovaro Biosciences ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Renovaro Biosciences has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Renovaro Biosciences a dividend aristocrat?
Renovaro Biosciences is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Renovaro Biosciences a dividend king?
Renovaro Biosciences is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Renovaro Biosciences a dividend stock?
No, Renovaro Biosciences is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Renovaro Biosciences stocks?
To buy Renovaro Biosciences you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Renovaro Biosciences stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.